Quality of life and physical functioning in HIV-infected individuals receiving antiretroviral therapy in KwaZulu-Natal, South Africa

Nursing and Health Sciences

Volumn 10, Issue 4, 2008, Pages 266-272

  McInerney, Patricia A ^a   Ncama, Busisiwe P ^a   Wantland, Dean ^b   Bhengu, Busisiwe R ^a   McGibbon, Chris ^e   Davis, Sheila M ^c   Corless, Inge B ^c   Nicholas, Patrice K ^c,d,f  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF NEW BRUNSWICK   (Canada)

^f NONE   (United States)

Author keywords

Adherence; HIV AIDS; Quality of life

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; COMORBIDITY; DISEASE DURATION; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SOCIAL INTERACTION; SOCIAL STATUS; SOCIAL SUPPORT; SOUTH AFRICA; TREATMENT DURATION; TUBERCULOSIS;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; SOUTH AFRICA;

EID: 56049120349     PISSN: 14410745     EISSN: 14422018     Source Type: Journal    
DOI: 10.1111/j.1442-2018.2008.00410.x     Document Type: Article

References (23)

1. Bakken S, Holzemer WL, Brown MA et al. Relationships between perception of engagement with health care provider and demographic characteristics, health status, and adherence to therapeutic regimen in persons with HIV/ AIDS. AIDS Patient Care STDS 2000; 14: 189-197.
2. Bangsberg DR, Charlebois ED, Grant RM et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS 2003; 17: 1925-1932. mutations
3. Bangsberg DR, Hecht FM, Charlebois ED et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000; 14: 357-366.
4. Dorrington RE, Johnson LF, Bradshaw D, Daniel T. The Demographic Impact of HIV/AIDS in South Africa. National and Provincial Indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Council/Actuarial Society of South Africa, 2006.
5. Gao X, Nau DP. Congruence of three self-report measures of medication adherence among HIV patients. Ann. Pharmacother. 2000; 34: 1117-1122.
6. Holzemer WL, Hudson A, Kirksey KM, Hamilton MJ, Bakken S. The revised Sign and Symptom Check-List for HIV (SSC-HIVrev). J. Assoc. Nurs. AIDS Care 2001; 12: 60-70.
7. Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: Long term incidence and risk factors in a South African cohort. AIDS 2005a; 19: 2109-2116.
8. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: Impact on treatment outcomes and implications for tuberculosis control. AIDS 2006; 20: 1605-1612.
9. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa. AIDS 2005b; 19: 2141-2148.
10. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 1994; 32: 40-66.
11. Machtinger EL, Bangsberg DR. Seven steps to better adherence: A practical approach to promoting adherence to antiretroviral therapy. AIDS Reader 2007; 17: 43-51.
12. McInerney P, Nicholas PK, Wantland D et al. Characteristics of adherence to anti-tuberculosis medications in South Africa. Appl. Nurs. Res. 2007; 20: 164-170.
13. Mannheimer SB, Matts J, Telzak E et al. Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence. AIDS Care 2005; 17: 10-22.
14. Mills EJ, Nachega JB, Buchan I et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 2006; 296: 679-690.
15. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care 1986; 24: 67-74.
16. Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis. J. Acq. Immune Defic. Syndr. 2005; 38: 445-448.
17. Paterson DL, Swindells S, Mohr J et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Intern. Med. 2000; 133: 21-30.
18. Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: Implications for antiretroviral therapy in resource-poor settings? Int. J. Tuberculosis Lung Dis. 2002; 9: 263-269.
19. Shariar J, Delate T, Hays RD, Coons SJ. Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health and Quality of Life Outcomes. 2003. [Cited 2 Nov 2007.]Available from URL: http://rand.org/pubs/reprints/2005/RP1100.pdf.
20. Sherbourne CD, Stewart AL. The MOS social support survey. Soc. Sci. Med. 1991; 32: 705-714.
21. United Nations Joint Programme on AIDS (UNAIDS). AIDS epidemic update. 2008. [Cited 14 Oct 2008]. Available from URL: http://www.unaids.org/en/ CountryResponses/Countries/south_africa.asp
22. Valenti WM. Treatment adherence improves outcomes and manages costs. AIDS Reader 2001; 11: 77-80.
23. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992; 30: 473-483.